DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Mitoquinone is an investigational drug.
There have been 5 clinical trials for Mitoquinone. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Hepatitis C, Chronic, Multiple Sclerosis, and Hepatitis C. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., Oregon Health and Science University, and MitoQ Ltd.
Recent Clinical Trials for Mitoquinone
|MitoQ on Fatigue in Multiple Sclerosis||MitoQ Ltd||Phase 1/Phase 2|
|MitoQ on Fatigue in Multiple Sclerosis||Oregon Health and Science University||Phase 1/Phase 2|
|The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults||University of Colorado, Boulder||N/A|